Form 8-K - Current report:
SEC Accession No. 0001104659-14-032304
Filing Date
2014-04-30
Accepted
2014-04-30 08:35:53
Documents
2
Period of Report
2014-04-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-11558_18k.htm 8-K 21868
2 EX-99.1 a14-11558_1ex99d1.htm EX-99.1 17663
  Complete submission text file 0001104659-14-032304.txt   40842
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35268 | Film No.: 14795971
SIC: 2834 Pharmaceutical Preparations